- Home
- ACIU vs SCPH Comparison
ACIU vs SCPH Comparison
Compare ACIU & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- SCPH
- Stock Information
- Founded
- ACIU 2003
- SCPH 2013
- Country
- ACIU Switzerland
- SCPH United States
- Employees
- ACIU N/A
- SCPH N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- ACIU Health Care
- SCPH Health Care
- Exchange
- ACIU Nasdaq
- SCPH Nasdaq
- Market Cap
- ACIU 213.3M
- SCPH 173.6M
- IPO Year
- ACIU 2016
- SCPH 2017
- Fundamental
- Price
- ACIU $2.04
- SCPH $5.50
- Analyst Decision
- ACIU Strong Buy
- SCPH Buy
- Analyst Count
- ACIU 1
- SCPH 3
- Target Price
- ACIU $12.00
- SCPH $12.00
- AVG Volume (30 Days)
- ACIU 109.7K
- SCPH 2.1M
- Earning Date
- ACIU 08-05-2025
- SCPH 08-07-2025
- Dividend Yield
- ACIU N/A
- SCPH N/A
- EPS Growth
- ACIU N/A
- SCPH N/A
- EPS
- ACIU N/A
- SCPH N/A
- Revenue
- ACIU $36,362,036.00
- SCPH $49,969,000.00
- Revenue This Year
- ACIU N/A
- SCPH $108.95
- Revenue Next Year
- ACIU $1,022.98
- SCPH $78.30
- P/E Ratio
- ACIU N/A
- SCPH N/A
- Revenue Growth
- ACIU 86.71
- SCPH 107.79
- 52 Week Low
- ACIU $1.43
- SCPH $1.94
- 52 Week High
- ACIU $3.98
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- ACIU 44.83
- SCPH 61.89
- Support Level
- ACIU $2.05
- SCPH $4.33
- Resistance Level
- ACIU $2.19
- SCPH $5.62
- Average True Range (ATR)
- ACIU 0.11
- SCPH 0.23
- MACD
- ACIU -0.01
- SCPH 0.07
- Stochastic Oscillator
- ACIU 4.55
- SCPH 90.70
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.